ArticleCell reports. Medicine2026

Syndecan-1-targeted therapeutic antibody impairs macropinocytosis and elicits antitumor immunity in pancreatic cancer.

Zecheng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.